Literature DB >> 23937882

Fondaparinux: an effective bridging strategy in heparin-induced thrombocytopenia and mechanical circulatory support.

Rochelle M Gellatly1, Angeline Leet2, Kathryn E Brown2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23937882     DOI： 10.1016/j.healun.2013.07.015

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  3 in total

Review 1.  Heparin induced thrombocytopenia with mechanical circulatory support devices: review of the literature and management considerations.

Authors:  Jonathan Bain; Alexander H Flannery; Jeremy Flynn; William Dager
Journal:  J Thromb Thrombolysis       Date:  2017-07       Impact factor: 2.300

Review 2.  Heparin-induced thrombocytopenia during extracorporeal life support: incidence, management and outcomes.

Authors:  Jae Hwan Choi; Jessica G Y Luc; Matthew P Weber; Haritha G Reddy; Elizabeth J Maynes; Avijit K Deb; Louis E Samuels; Rohinton J Morris; H Todd Massey; Antonio Loforte; Vakhtang Tchantchaleishvili
Journal:  Ann Cardiothorac Surg       Date:  2019-01

3.  A retrospective evaluation of fondaparinux for confirmed or suspected heparin-induced thrombocytopenia in left-ventricular-assist device patients.

Authors:  Scott T Benken; Nicholas Tillman; Suhuir Dajani; Aesha Shah; Toby Thomas
Journal:  J Cardiothorac Surg       Date:  2014-03-21       Impact factor: 1.637
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.